3-186613180-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_001622.4(AHSG):āc.39C>Gā(p.Leu13Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 1,613,722 control chromosomes in the GnomAD database, including 21,309 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.19 ( 3506 hom., cov: 31)
Exomes š: 0.15 ( 17803 hom. )
Consequence
AHSG
NM_001622.4 synonymous
NM_001622.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.124
Genes affected
AHSG (HGNC:349): (alpha 2-HS glycoprotein) The protein encoded by this gene is a negatively-charged serum glycoprotein that is synthesized by hepatocytes. The encoded protein consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several processes, including endocytosis, brain development, and the formation of bone tissue. Defects in this gene are a cause of susceptibility to leanness. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 3-186613180-C-G is Benign according to our data. Variant chr3-186613180-C-G is described in ClinVar as [Benign]. Clinvar id is 3058930.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.124 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.326 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHSG | NM_001622.4 | c.39C>G | p.Leu13Leu | synonymous_variant | 1/7 | ENST00000411641.7 | NP_001613.2 | |
AHSG | NM_001354571.2 | c.39C>G | p.Leu13Leu | synonymous_variant | 1/7 | NP_001341500.1 | ||
AHSG | NM_001354572.2 | c.39C>G | p.Leu13Leu | synonymous_variant | 1/7 | NP_001341501.1 | ||
AHSG | NM_001354573.2 | c.39C>G | p.Leu13Leu | synonymous_variant | 1/6 | NP_001341502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHSG | ENST00000411641.7 | c.39C>G | p.Leu13Leu | synonymous_variant | 1/7 | 1 | NM_001622.4 | ENSP00000393887.2 |
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29543AN: 151920Hom.: 3500 Cov.: 31
GnomAD3 genomes
AF:
AC:
29543
AN:
151920
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.158 AC: 39644AN: 251210Hom.: 3701 AF XY: 0.158 AC XY: 21416AN XY: 135802
GnomAD3 exomes
AF:
AC:
39644
AN:
251210
Hom.:
AF XY:
AC XY:
21416
AN XY:
135802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.149 AC: 218115AN: 1461684Hom.: 17803 Cov.: 33 AF XY: 0.150 AC XY: 109076AN XY: 727162
GnomAD4 exome
AF:
AC:
218115
AN:
1461684
Hom.:
Cov.:
33
AF XY:
AC XY:
109076
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.194 AC: 29560AN: 152038Hom.: 3506 Cov.: 31 AF XY: 0.191 AC XY: 14177AN XY: 74334
GnomAD4 genome
AF:
AC:
29560
AN:
152038
Hom.:
Cov.:
31
AF XY:
AC XY:
14177
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
580
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
AHSG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 29, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at